A citation-based method for searching scientific literature

E H Aylward, B F Sparks, K M Field, V Yallapragada, B D Shpritz, A Rosenblatt, J Brandt, L M Gourley, K Liang, H Zhou, R L Margolis, C A Ross. Neurology 2004
Times Cited: 285







List of co-cited articles
882 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.
Sarah J Tabrizi, Douglas R Langbehn, Blair R Leavitt, Raymund Ac Roos, Alexandra Durr, David Craufurd, Christopher Kennard, Stephen L Hicks, Nick C Fox, Rachael I Scahill,[...]. Lancet Neurol 2009
633
42

Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Sarah J Tabrizi, Rachael I Scahill, Gail Owen, Alexandra Durr, Blair R Leavitt, Raymund A Roos, Beth Borowsky, Bernhard Landwehrmeyer, Chris Frost, Hans Johnson,[...]. Lancet Neurol 2013
479
39


Detection of Huntington's disease decades before diagnosis: the Predict-HD study.
J S Paulsen, D R Langbehn, J C Stout, E Aylward, C A Ross, M Nance, M Guttman, S Johnson, M MacDonald, L J Beglinger,[...]. J Neurol Neurosurg Psychiatry 2008
533
37


Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
30

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
Sarah J Tabrizi, Ralf Reilmann, Raymund A C Roos, Alexandra Durr, Blair Leavitt, Gail Owen, Rebecca Jones, Hans Johnson, David Craufurd, Stephen L Hicks,[...]. Lancet Neurol 2012
353
29

Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
Sarah J Tabrizi, Rachael I Scahill, Alexandra Durr, Raymund Ac Roos, Blair R Leavitt, Rebecca Jones, G Bernhard Landwehrmeyer, Nick C Fox, Hans Johnson, Stephen L Hicks,[...]. Lancet Neurol 2011
381
26

A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.
D R Langbehn, R R Brinkman, D Falush, J S Paulsen, M R Hayden. Clin Genet 2004
518
25

Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity.
H Diana Rosas, David H Salat, Stephanie Y Lee, Alexandra K Zaleta, Vasanth Pappu, Bruce Fischl, Doug Greve, Nathanael Hevelone, Steven M Hersch. Brain 2008
316
23

Striatal and white matter predictors of estimated diagnosis for Huntington disease.
Jane S Paulsen, Peggy C Nopoulos, Elizabeth Aylward, Christopher A Ross, Hans Johnson, Vincent A Magnotta, Andrew Juhl, Ronald K Pierson, James Mills, Douglas Langbehn,[...]. Brain Res Bull 2010
165
23

Huntington disease: natural history, biomarkers and prospects for therapeutics.
Christopher A Ross, Elizabeth H Aylward, Edward J Wild, Douglas R Langbehn, Jeffrey D Long, John H Warner, Rachael I Scahill, Blair R Leavitt, Julie C Stout, Jane S Paulsen,[...]. Nat Rev Neurol 2014
526
20

CAG repeat number governs the development rate of pathology in Huntington's disease.
J B Penney, J P Vonsattel, M E MacDonald, J F Gusella, R H Myers. Ann Neurol 1997
466
18

Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.
Jane S Paulsen, Jeffrey D Long, Christopher A Ross, Deborah L Harrington, Cheryl J Erwin, Janet K Williams, Holly James Westervelt, Hans J Johnson, Elizabeth H Aylward, Ying Zhang,[...]. Lancet Neurol 2014
140
17

Neurocognitive signs in prodromal Huntington disease.
Julie C Stout, Jane S Paulsen, Sarah Queller, Andrea C Solomon, Kathryn B Whitlock, J Colin Campbell, Noelle Carlozzi, Kevin Duff, Leigh J Beglinger, Douglas R Langbehn,[...]. Neuropsychology 2011
247
16

Preparing for preventive clinical trials: the Predict-HD study.
Jane S Paulsen, Michael Hayden, Julie C Stout, Douglas R Langbehn, Elizabeth Aylward, Christopher A Ross, Mark Guttman, Martha Nance, Karl Kieburtz, David Oakes,[...]. Arch Neurol 2006
229
16

Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study.
Jane S Paulsen, Jeffrey D Long, Hans J Johnson, Elizabeth H Aylward, Christopher A Ross, Janet K Williams, Martha A Nance, Cheryl J Erwin, Holly J Westervelt, Deborah L Harrington,[...]. Front Aging Neurosci 2014
131
15

Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study.
G Douaud, V Gaura, M-J Ribeiro, F Lethimonnier, R Maroy, C Verny, P Krystkowiak, P Damier, A-C Bachoud-Levi, P Hantraye,[...]. Neuroimage 2006
184
14

Brain structure in preclinical Huntington's disease.
Jane S Paulsen, Vince A Magnotta, Ania E Mikos, Henry L Paulson, Elizabeth Penziner, Nancy C Andreasen, Peg C Nopoulos. Biol Psychiatry 2006
172
14


Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures.
H Diana Rosas, David S Tuch, Nathanael D Hevelone, Alexandra K Zaleta, Mark Vangel, Steven M Hersch, David H Salat. Mov Disord 2006
242
14

Longitudinal change in regional brain volumes in prodromal Huntington disease.
Elizabeth H Aylward, Peggy C Nopoulos, Christopher A Ross, Douglas R Langbehn, Ronald K Pierson, James A Mills, Hans J Johnson, Vincent A Magnotta, Andrew R Juhl, Jane S Paulsen. J Neurol Neurosurg Psychiatry 2011
162
13

Striatal volume loss in HD as measured by MRI and the influence of CAG repeat.
H D Rosas, J Goodman, Y I Chen, B G Jenkins, D N Kennedy, N Makris, M Patti, L J Seidman, M F Beal, W J Koroshetz. Neurology 2001
103
13

Indexing disease progression at study entry with individuals at-risk for Huntington disease.
Ying Zhang, Jeffrey D Long, James A Mills, John H Warner, Wenjing Lu, Jane S Paulsen. Am J Med Genet B Neuropsychiatr Genet 2011
141
12

Cerebral cortex structure in prodromal Huntington disease.
Peggy C Nopoulos, Elizabeth H Aylward, Christopher A Ross, Hans J Johnson, Vincent A Magnotta, Andrew R Juhl, Ronald K Pierson, James Mills, Douglas R Langbehn, Jane S Paulsen. Neurobiol Dis 2010
94
12

CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches.
Douglas R Langbehn, Michael R Hayden, Jane S Paulsen. Am J Med Genet B Neuropsychiatr Genet 2010
203
12

Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical "disconnection".
H Diana Rosas, Stephanie Y Lee, Alexander C Bender, Alexandra K Zaleta, Mark Vangel, Peng Yu, Bruce Fischl, Vasanth Pappu, Christina Onorato, Jang-Ho Cha,[...]. Neuroimage 2010
178
12

Huntington disease.
Gillian P Bates, Ray Dorsey, James F Gusella, Michael R Hayden, Chris Kay, Blair R Leavitt, Martha Nance, Christopher A Ross, Rachael I Scahill, Ronald Wetzel,[...]. Nat Rev Dis Primers 2015
558
12

Regional cortical thinning in preclinical Huntington disease and its relationship to cognition.
H D Rosas, N D Hevelone, A K Zaleta, D N Greve, D H Salat, B Fischl. Neurology 2005
228
11

Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis.
H D Rosas, W J Koroshetz, Y I Chen, C Skeuse, M Vangel, M E Cudkowicz, K Caplan, K Marek, L J Seidman, N Makris,[...]. Neurology 2003
366
11

Huntington's disease: from molecular pathogenesis to clinical treatment.
Christopher A Ross, Sarah J Tabrizi. Lancet Neurol 2011
895
10

Voxel-based morphometry--the methods.
J Ashburner, K J Friston. Neuroimage 2000
10

Neural correlates associated with impaired disgust processing in pre-symptomatic Huntington's disease.
A Hennenlotter, U Schroeder, P Erhard, B Haslinger, R Stahl, A Weindl, H G von Einsiedel, K W Lange, A O Ceballos-Baumann. Brain 2004
126
10


Huntington disease: clinical care and evaluation.
I Shoulson, S Fahn. Neurology 1979
553
10

White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease.
Stefan Klöppel, Bogdan Draganski, Charlotte V Golding, Carlton Chu, Zoltan Nagy, Philip A Cook, Stephen L Hicks, Christopher Kennard, Daniel C Alexander, Geoff J M Parker,[...]. Brain 2008
127
10

Longitudinal change in basal ganglia volume in patients with Huntington's disease.
E H Aylward, Q Li, O C Stine, N Ranen, M Sherr, P E Barta, F W Bylsma, G D Pearlson, C A Ross. Neurology 1997
150
10

Multi-modal neuroimaging in premanifest and early Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.
Juan F Domínguez D, Gary F Egan, Marcus A Gray, Govinda R Poudel, Andrew Churchyard, Phyllis Chua, Julie C Stout, Nellie Georgiou-Karistianis. PLoS One 2013
59
16

Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy.
Rachael I Scahill, Nicola Z Hobbs, Miranda J Say, Natalie Bechtel, Susie M D Henley, Harpreet Hyare, Douglas R Langbehn, Rebecca Jones, Blair R Leavitt, Raymund A C Roos,[...]. Hum Brain Mapp 2013
75
12

The distribution of structural neuropathology in pre-clinical Huntington's disease.
M J Thieben, A J Duggins, C D Good, L Gomes, N Mahant, F Richards, E McCusker, R S J Frackowiak. Brain 2002
209
9

Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease.
India Bohanna, Nellie Georgiou-Karistianis, Anthony J Hannan, Gary F Egan. Brain Res Rev 2008
120
9

Frontal lobe volume in patients with Huntington's disease.
E H Aylward, N B Anderson, F W Bylsma, M V Wagster, P E Barta, M Sherr, J Feeney, A Davis, A Rosenblatt, G D Pearlson,[...]. Neurology 1998
133
9

Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.
H H Ruocco, L Bonilha, L M Li, I Lopes-Cendes, F Cendes. J Neurol Neurosurg Psychiatry 2008
83
10

Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons.
E H Aylward, J Brandt, A M Codori, R S Mangus, P E Barta, G J Harris. Neurology 1994
140
9

Consistent neurodegeneration and its association with clinical progression in Huntington's disease: a coordinate-based meta-analysis.
Imis Dogan, Simon B Eickhoff, Jörg B Schulz, N Jon Shah, Angela R Laird, Peter T Fox, Kathrin Reetz. Neurodegener Dis 2013
50
18

Regional atrophy associated with cognitive and motor function in prodromal Huntington disease.
Elizabeth H Aylward, Deborah L Harrington, James A Mills, Peggy C Nopoulos, Christopher A Ross, Jeffrey D Long, Dawei Liu, Holly K Westervelt, Jane S Paulsen. J Huntingtons Dis 2013
43
20

Behavioral changes in Huntington Disease.
D Craufurd, J C Thompson, J S Snowden. Neuropsychiatry Neuropsychol Behav Neurol 2001
267
9

Early atrophy of pallidum and accumbens nucleus in Huntington's disease.
Simon J A van den Bogaard, Eve M Dumas, Tanka P Acharya, Hans Johnson, Douglas R Langbehn, Rachael I Scahill, Sarah J Tabrizi, Mark A van Buchem, Jeroen van der Grond, Raymund A C Roos. J Neurol 2011
81
11

Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study.
Stefan Klöppel, Sarah Gregory, Elisa Scheller, Lora Minkova, Adeel Razi, Alexandra Durr, Raymund A C Roos, Blair R Leavitt, Marina Papoutsi, G Bernhard Landwehrmeyer,[...]. EBioMedicine 2015
79
11

Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis.
Jan Kassubek, Freimut D Juengling, Daniel Ecker, G Bernhard Landwehrmeyer. Cereb Cortex 2005
121
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.